Forgot your password?
New user?
Nanoparticle fear over anti-odour socks
Fragment-based Lead Discovery Conference 2008
test conference
Document Actions
NGS for Drugs, Patients and Clinical Trials Conference
| Type | Conference |
|---|---|
| Language | English |
| Date |
March 21, 2013
to March 22, 2013 |
| Venue |
Hilton San Diego Resort 1775 East Mission Bay Drive San Diego, CA 92109 US |
| Chemistry Specialties |
|
| Chemistry Techniques |
|
| Contact |
Kris Waterman Cambridge Healthtech Institute 250 First Ave. Needham, MA 02494 US 781-972-5413 781-972-5425 kwaterman@healthtech.com |
| Add event to calendar |
vCal (Windows, Linux)
iCal (Mac OS X)
|
Next-Generation Sequencing (NGS), along with a shift toward personalized medicine, is poised to revolutionize the drug discovery paradigm by offering unprecedented interrogation of the human genome at high resolution, and relatively low costs. While the widespread implementation of NGS is apparent, issues specific to drug development present new challenges for developers, including discerning actionable genomic information for novel targets, markers and utilization in clinical trials; developing informatics infrastructure and pipelines to deal with the computational complexity of NGS data; and navigating regulatory hurdles of informed consent and data sharing. Cambridge Healthtech Institute is proud to announce the Inaugural NGS for Drugs, Patients and Clinical Trials, designed with drug developers in mind, to explore the unparalleled advantages of NGS technologies for translational research, while addressing common challenges.